| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 35.8 | 35.1 | 28.4 |
| Total income | 35.8 | 35.1 | 28.4 |
| Profit before exceptional items & tax | 4.0 | 4.0 | 3.3 |
| Profit before tax | 4.0 | 4.0 | 3.3 |
| Net profit | 3.0 | 3.0 | 2.5 |
| Operating margin | 11.2% | 11.4% | 11.6% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +20.00% |
|---|---|
| Net profit, quarter on quarter | +0.00% |
| Revenue, year on year | +26.10% |
Source
Read the filing ↗
NSE results filing, NSE: MEDISTEP. Figures extracted from the filing.
Medistep Healthcare Ltd: key numbers
- Share price
- ₹19.50
- Market cap
- ₹27.71 Cr
- Revenue (annual)
- ₹70.83 Cr
- Net profit (annual)
- ₹5.98 Cr
- P/E (TTM)
- 4.6×Sector 50.4×
- Promoter holding
- 68.96%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Medistep Healthcare Ltd
All →
16:27 IST
NSE
Annual General Meeting
Medistep Healthcare Annual General Meeting
Medistep Healthcare Limited held its 3rd Annual General Meeting on September 17, 2026. Shareholders transacted on financial statements, director re-appointment, and investment thresholds.